Three-dimensional (3D) anatomic location, extension, and timing of severe osteoradionecrosis of the mandible.

head and neck cancer late toxicity radiotherapy

Journal

Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology
ISSN: 1507-1367
Titre abrégé: Rep Pract Oncol Radiother
Pays: Poland
ID NLM: 100885761

Informations de publication

Date de publication:
2022
Historique:
received: 06 02 2022
accepted: 13 04 2022
entrez: 3 10 2022
pubmed: 4 10 2022
medline: 4 10 2022
Statut: epublish

Résumé

The purpose of this study was to describe the topography, extension (volume), and timing of severe osteoradionecrosis (ORN) that required mandible resection in patients previously treated for head and neck cancer at a high-volume Veterans Affairs Medical Center. The records from a reference hyperbaric oxygen clinic were retrospectively analyzed (n = 50, 2018-2021). Inclusion criteria were: I) severe ORN defined as progressive ORN that required resection; II) pathologic confirmation of ORN; and III) availability of pre-operative CT-imaging. Using a radiotherapy (RT) imaging software, we performed a detailed volumetric (3D) analysis of the bone involvement by ORN. Time intervals from RT to surgery for ORN and from surgery to the last follow-up were calculated. All patients that met inclusion criteria (n = 10) were male with significant smoking history (median 47.5 pack-years) and a median age of 57 years old at the time of RT. The primary tumors were: oropharynx (n = 6), oral cavity (n = 3) and nasopharynx (n = 1). The median time from RT to ORN surgery was 8 years. The most common ORN location was the posterior lateral body (molar) and six patients had associated fractures. The mean ORN volume was 3.6 cc (range: 0.6-8.3), corresponding to a mean 6.3% (range: 0.7-14) of the total mandibular volume. After a median follow-up of 13.5 months, no recurrence of ORN occurred. Three patients died of non-cancer and non-ORN-recurrence related causes (1 y OS 77.1%). Severe ORN occurred after a median of 8 years from the previous RT and usually affected the posterior lateral body. Surgical resection achieved excellent ORN control.

Sections du résumé

Background UNASSIGNED
The purpose of this study was to describe the topography, extension (volume), and timing of severe osteoradionecrosis (ORN) that required mandible resection in patients previously treated for head and neck cancer at a high-volume Veterans Affairs Medical Center.
Materials and methods UNASSIGNED
The records from a reference hyperbaric oxygen clinic were retrospectively analyzed (n = 50, 2018-2021). Inclusion criteria were: I) severe ORN defined as progressive ORN that required resection; II) pathologic confirmation of ORN; and III) availability of pre-operative CT-imaging. Using a radiotherapy (RT) imaging software, we performed a detailed volumetric (3D) analysis of the bone involvement by ORN. Time intervals from RT to surgery for ORN and from surgery to the last follow-up were calculated.
Results UNASSIGNED
All patients that met inclusion criteria (n = 10) were male with significant smoking history (median 47.5 pack-years) and a median age of 57 years old at the time of RT. The primary tumors were: oropharynx (n = 6), oral cavity (n = 3) and nasopharynx (n = 1). The median time from RT to ORN surgery was 8 years. The most common ORN location was the posterior lateral body (molar) and six patients had associated fractures. The mean ORN volume was 3.6 cc (range: 0.6-8.3), corresponding to a mean 6.3% (range: 0.7-14) of the total mandibular volume. After a median follow-up of 13.5 months, no recurrence of ORN occurred. Three patients died of non-cancer and non-ORN-recurrence related causes (1 y OS 77.1%).
Conclusion UNASSIGNED
Severe ORN occurred after a median of 8 years from the previous RT and usually affected the posterior lateral body. Surgical resection achieved excellent ORN control.

Identifiants

pubmed: 36186684
doi: 10.5603/RPOR.a2022.0057
pii: rpor-27-3-519
pmc: PMC9518768
doi:

Types de publication

Journal Article

Langues

eng

Pagination

519-526

Informations de copyright

© 2022 Greater Poland Cancer Centre.

Déclaration de conflit d'intérêts

Conflicts of interest None declared.

Références

Oral Oncol. 2017 Jan;64:44-51
pubmed: 28024723
Br J Oral Maxillofac Surg. 2008 Dec;46(8):653-60
pubmed: 18562055
J Oral Maxillofac Surg. 1983 May;41(5):283-8
pubmed: 6572704
Int J Radiat Oncol Biol Phys. 2020 Dec 1;108(5):1319-1328
pubmed: 32712257
Laryngoscope. 1993 Jun;103(6):605-8
pubmed: 8502093
Ann Plast Surg. 2004 Jan;52(1):31-5
pubmed: 14676696
Cancer. 2017 Oct 1;123(19):3691-3700
pubmed: 28608925
J Oral Maxillofac Surg. 2000 Oct;58(10):1088-93; discussion 1093-5
pubmed: 11021701
Radiother Oncol. 2017 Aug;124(2):232-239
pubmed: 28733053
Plast Reconstr Surg. 2002 May;109(6):1875-81
pubmed: 11994586
Am J Clin Oncol. 2002 Apr;25(2):168-71
pubmed: 11943896
Radiat Oncol. 2021 Jul 14;16(1):130
pubmed: 34261515
J Oral Maxillofac Surg. 1987 Feb;45(2):104-10
pubmed: 3468211
Int J Radiat Oncol Biol Phys. 1995 Oct 15;33(3):563-8
pubmed: 7558944
Int J Oral Maxillofac Surg. 2003 Jun;32(3):289-95
pubmed: 12767877
Eur Heart J. 1999 Mar;20(5):344-53
pubmed: 10206381
Int J Radiat Oncol Biol Phys. 2011 Jul 1;80(3):832-9
pubmed: 20638190
Int J Oral Maxillofac Surg. 2019 Feb;48(2):173-180
pubmed: 30205911
Int J Radiat Oncol Biol Phys. 2021 Oct 1;111(2):549-558
pubmed: 33965514
Head Neck. 2003 Mar;25(3):181-6
pubmed: 12599284
Radiat Oncol. 2021 Jan 5;16(1):1
pubmed: 33402192
Head Neck. 2009 Mar;31(3):361-70
pubmed: 19073007
BMJ. 1998 Oct 24;317(7166):1140-3
pubmed: 9784458
Acta Otolaryngol. 2020 Dec;140(12):1049-1055
pubmed: 32921212
Front Artif Intell. 2021 Apr 09;4:618469
pubmed: 33898983
Int J Radiat Oncol Biol Phys. 2013 Feb 1;85(2):415-20
pubmed: 22795804
Radiother Oncol. 1995 Aug;36(2):94-100
pubmed: 7501817

Auteurs

Lucas G Sapienza (LG)

Department of Radiation Oncology, Dan L Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX, United States.

Justin J Thomas (JJ)

Department of Radiation Oncology, Dan L Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX, United States.

Weiyuan Mai (W)

Department of Radiation Oncology, Dan L Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX, United States.
Department of Radiation Oncology, Michael E. DeBakey Veterans Affairs Medical Center, Houston, TX, United States.

Alexander N Hanania (AN)

Department of Radiation Oncology, Dan L Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX, United States.

Sandeep Hunjan (S)

Department of Radiation Oncology, Michael E. DeBakey Veterans Affairs Medical Center, Houston, TX, United States.

Vlad C Sandulache (VC)

ENT Section - Operative Care Line, Michael E. DeBakey Veterans Affairs Medical Center, Houston, TX, United States.
Bobby R. Alford Department of Otolaryngology - Head and Neck Surgery, Baylor College of Medicine, Houston, TX, United States.

Albert C Chen (AC)

Department of Radiation Oncology, Dan L Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX, United States.
Department of Radiation Oncology, Michael E. DeBakey Veterans Affairs Medical Center, Houston, TX, United States.

Classifications MeSH